{"article_title": "'60 Minutes' Just Attacked High Drug Prices. Here's What You Should Know.", "article_keywords": ["60", "attacked", "heres", "drug", "high", "know", "prices", "minutes"], "article_url": "http://www.forbes.com/sites/matthewherper/2014/10/05/60-minutes-just-attacked-high-drug-prices-heres-what-you-should-know/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Matthew Herper", "og": {"site_name": "Forbes", "description": "60 Minutes, the most successful news program in American history, just took aim at the extraordinarily high ($100,000 per patient per year) prices charged for cancer drugs. The pharmaceutical industry, which only provided canned statements and badly thought-out explanation via the president of its lobbying group, came off looking callous [...]", "title": "'60 Minutes' Just Attacked High Drug Prices. Here's What You Should Know.", "url": "http://www.forbes.com/sites/matthewherper/2014/10/05/60-minutes-just-attacked-high-drug-prices-heres-what-you-should-know/", "image": "http://blogs-images.forbes.com/matthewherper/files/2014/10/98d336da0f13a2dece939a6a784d8f60_11589.jpg", "updated_time": "2014-10-06T10:59:19-04:00", "type": "article"}, "twitter": {"description": "60 Minutes, the most successful news program in American history, just took aim at the extraordinarily high ($100,000 per patient per year) prices charged for cancer drugs. The pharmaceutical industry, which only provided canned statements and badly thought-out explanation via the president of its lobbying group, came off looking callous [...]", "title": "'60 Minutes' Just Attacked High Drug Prices. Here's What You Should Know.", "image": "http://blogs-images.forbes.com/matthewherper/files/2014/10/98d336da0f13a2dece939a6a784d8f60_11589.jpg", "creator": "@matthewherper", "site": "@forbes", "card": "summary_large_image"}, "description": "60 Minutes, the most successful news program in American history, just took aim at the extraordinarily high ($100,000 per patient per year) prices charged for cancer drugs. The pharmaceutical industry, which only provided canned statements and badly thought-out explanation via the president of its lobbying group, came off looking callous [...]", "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Pharma and Health,Washington,Pharma &amp; Healthcare", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/herper", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-10-06", "published": "2014-10-05", "id": "blogAndPostId/blog/post/973-11589"}, "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "news_keywords": "Business,Pharma and Health,Washington,Pharma &amp; Healthcare"}, "_id": "\"57477af36914bd0286fd1a90\"", "article_summary": ""}